Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmin chelates pty. ltd. - copper as bis-ethylenediamine copper complex - liquid - copper as bis-ethylenediamine copper complex mineral-copper active 110.0 g/l - algicide - farm dam | irrigation channel | ornamental lake | pond, stagnant water, drain pest control | potable water - see label for exclu - algae | algae - filamentous (mat forming) | algae - planktonic (suspended) | chara spp. | cyanobacteria | green algae | string or hair algae | cladophora spp. | hydrodictyon spp. | microcystis | oedogenium spp. | oscillatoria | spirogyra | spirogyra spp. | ulothrix

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmin chelates pty. ltd. - copper present as copper ethanolamine complex - liquid - copper present as copper ethanolamine complex mineral-copper active 105.0 g/l - algicide - farm dam | irrigation channel | ornamental lake | pond, stagnant water, drain pest control | potable water - see label for exclu - algae - filamentous (mat forming) | algae - planktonic (suspended) | blue-green algae - phormidium spp. | stonewort - chara spp. | stonewort - nitella spp. | bluegreen algae | cladophora spp. | filamentous blue-green algae | hydrodictyon spp. | oedogenium spp. | spirogyra spp.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

agmin chelates pty. ltd. - aliphatic carboxylic acid; non-ionic surfactants mixture - liquid - aliphatic carboxylic acid acid-carboxylic active 350.0 g/l; non-ionic surfactants mixture emulsifiers & surfactants active 200.0 g/l - surfactant - agricultural chemical additive | spray activator | spreading agent | wetting agent - acidifier | wetting agent (use as directed) | improve penetrating properties | to lower ph

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dalteparin sodium, quantity: 10000 anti-xa iu/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dalteparin sodium, quantity: 7500 anti-xa iu - injection, solution - excipient ingredients: water for injections; sodium chloride - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dalteparin sodium, quantity: 12500 anti-xa iu - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dalteparin sodium, quantity: 15000 anti-xa iu - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dalteparin sodium, quantity: 18000 anti-xa iu - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dalteparin sodium, quantity: 5000 anti-xa iu - injection, solution - excipient ingredients: water for injections - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dalteparin sodium, quantity: 2500 anti-xa iu - injection, solution - excipient ingredients: water for injections; sodium chloride - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.